Tag: ultrasound

Heartflow Plaque Analysis to be Covered by UnitedHealthcare Plans Nationwide

Largest commercial insurer in the United States releases positive comprehensive coverage for AI-enabled Heartflow Plaque Analysis to support precise diagnosis and management of patients

Largest commercial insurer in the United States releases positive comprehensive coverage for AI-enabled Heartflow Plaque Analysis to support precise diagnosis and management of patients

Texas Cardiac Arrhythmia Institute at St. David’s Medical Center first in U.S. to use FDA-approved novel wireless system to treat cardiac arrhythmias

AUSTIN, Texas, July 21, 2025 /PRNewswire/ -- Electrophysiologists at the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center recently became the first...

Texas Cardiac Arrhythmia Institute at St. David’s Medical Center first in U.S. to use FDA-approved novel wireless system to treat cardiac arrhythmias

AUSTIN, Texas, July 21, 2025 /PRNewswire/ -- Electrophysiologists at the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center recently became the first...

Texas Cardiac Arrhythmia Institute at St. David’s Medical Center first in U.S. to use FDA-approved novel wireless system to treat cardiac arrhythmias

AUSTIN, Texas, July 21, 2025 /PRNewswire/ -- Electrophysiologists at the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center recently became the first...

Aquablation® Therapy’s Assigned Category I Code in 2026 Medicare Proposed Physician Fee Schedule

SAN JOSE, Calif., July 14, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company dedicated to advancing patient care through transformative urology solutions, today announced that Aquablation therapy was assigned a Category I code effective January 1, 2026.

Artificial Intelligence (AI) in Radiology Market to Reach USD 4236 Million by 2031 | 9% CAGR Growth Driven by Cloud & On-Premise Solutions –...

Artificial Intelligence in Radiology Market is Segmented by Type (Cloud Based, On-Premise), by Application (Hospital, Biomedical Company, Academic Institution). BANGALORE, India , July 11, 2025 /PRNewswire/...

Artificial Intelligence (AI) in Radiology Market to Reach USD 4236 Million by 2031 | 9% CAGR Growth Driven by Cloud & On-Premise Solutions –...

Artificial Intelligence in Radiology Market is Segmented by Type (Cloud Based, On-Premise), by Application (Hospital, Biomedical Company, Academic Institution). BANGALORE, India , July 11, 2025 /PRNewswire/...

Bracco Imaging Earns EcoVadis Platinum Medal for Global Sustainability Leadership

Award places company in top 1% of organizations rated globally for environmental, social, and ethical practices MILAN, July 10, 2025 /PRNewswire/ -- Bracco Imaging, a...

Bracco Imaging Earns EcoVadis Platinum Medal for Global Sustainability Leadership

Award places company in top 1% of organizations rated globally for environmental, social, and ethical practices MILAN, July 10, 2025 /PRNewswire/ -- Bracco Imaging, a...

SEVEN WEEKS COFFEE DONATES $1 MILLION TO PRO-LIFE ORGANIZATIONS

LEESBURG, Va., July 7, 2025 /PRNewswire/ -- The 2000s had Toms Shoes. The 2020s have Seven Weeks Coffee. ...

Peer-Reviewed Study in Nature Scientific Reports Demonstrates Non-Invasive Fat Reduction Using Alma’s Energy-Based Technology

CAESAREA, Israel, June 27, 2025 /PRNewswire/ -- A newly published, peer-reviewed study in Nature Scientific Reports, part of the prestigious Nature Portfolio, presents compelling clinical...

Peer-Reviewed Study in Nature Scientific Reports Demonstrates Non-Invasive Fat Reduction Using Alma’s Energy-Based Technology

CAESAREA, Israel, June 27, 2025 /PRNewswire/ -- A newly published, peer-reviewed study in Nature Scientific Reports, part of the prestigious Nature Portfolio, presents compelling clinical...

Blue Earth Therapeutics: SNMMI Presentation of Results from Lutetium (177Lu) rhPSMA-10.1 Injection Phase 1 Clinical Trial

− Results show delivery of high radiation doses to tumours compared with normal organs.− Observed normal organ absorbed dosimetry results may allow administration of...

Blue Earth Therapeutics: SNMMI Presentation of Results from Lutetium (177Lu) rhPSMA-10.1 Injection Phase 1 Clinical Trial

− Results show delivery of high radiation doses to tumours compared with normal organs.− Observed normal organ absorbed dosimetry results may allow administration of...

Massage Envy Celebrates 20 Million Skin Care Services Milestone

ChiroTouch and Aloha Form Preferred Partnership to Support Chiropractic Practices with Patient Engagement Solutions

IDEMIA Public Security and Nevetal Partner to Enable Secure and Seamless Digital Cruise Passenger Journeys

Heartflow Plaque Analysis to be Covered by UnitedHealthcare Plans Nationwide

Texas Cardiac Arrhythmia Institute at St. David’s Medical Center first in U.S. to use FDA-approved novel wireless system to treat cardiac arrhythmias

Texas Cardiac Arrhythmia Institute at St. David’s Medical Center first in U.S. to use FDA-approved novel wireless system to treat cardiac arrhythmias

Texas Cardiac Arrhythmia Institute at St. David’s Medical Center first in U.S. to use FDA-approved novel wireless system to treat cardiac arrhythmias

Aquablation® Therapy’s Assigned Category I Code in 2026 Medicare Proposed Physician Fee Schedule

Artificial Intelligence (AI) in Radiology Market to Reach USD 4236 Million by 2031 | 9% CAGR Growth Driven by Cloud & On-Premise Solutions –...

Artificial Intelligence (AI) in Radiology Market to Reach USD 4236 Million by 2031 | 9% CAGR Growth Driven by Cloud & On-Premise Solutions –...

Bracco Imaging Earns EcoVadis Platinum Medal for Global Sustainability Leadership

Bracco Imaging Earns EcoVadis Platinum Medal for Global Sustainability Leadership

SEVEN WEEKS COFFEE DONATES $1 MILLION TO PRO-LIFE ORGANIZATIONS

Peer-Reviewed Study in Nature Scientific Reports Demonstrates Non-Invasive Fat Reduction Using Alma’s Energy-Based Technology

Peer-Reviewed Study in Nature Scientific Reports Demonstrates Non-Invasive Fat Reduction Using Alma’s Energy-Based Technology

Blue Earth Therapeutics: SNMMI Presentation of Results from Lutetium (177Lu) rhPSMA-10.1 Injection Phase 1 Clinical Trial

Blue Earth Therapeutics: SNMMI Presentation of Results from Lutetium (177Lu) rhPSMA-10.1 Injection Phase 1 Clinical Trial

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us